Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
- PMID: 32283153
- PMCID: PMC7151466
- DOI: 10.1016/j.jinf.2020.03.039
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
Keywords: COVID-19; Corticosteroid; SARS-CoV-2; Viral clearance.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no competing interests.
Comment in
-
Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.J Infect. 2020 Aug;81(2):e79-e81. doi: 10.1016/j.jinf.2020.05.004. Epub 2020 May 8. J Infect. 2020. PMID: 32389783 Free PMC article. No abstract available.
-
The proper use of corticosteroids for 2019-nCov pneumonia: Towards promising results?J Infect. 2021 Jan;82(1):e6-e7. doi: 10.1016/j.jinf.2020.08.001. Epub 2020 Aug 5. J Infect. 2021. PMID: 32763262 Free PMC article. No abstract available.
Comment on
-
Clinical progression of patients with COVID-19 in Shanghai, China.J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19. J Infect. 2020. PMID: 32171869 Free PMC article.
References
-
- National Health Commission of the People's Republic of China. The 5th trial version of Diagnosis and Treatment Scheme for Pneumonitis with 2019-nCoV Infection (In Chinese). [cited 2020 Mar 20]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e1... (2020).
-
- Arabi Y.M., Mandourah Y., Al-Hameed F., Sindi A.A., Al Mekhlafi G.A., Hussein M.A. Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome. Am J Respir Crit Care Med. 2018;197(6):757–767. PMID: 29161116. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
